New Study Helps Explain Why Virus Can't Replicate in Human Cells Could Improve Vaccines

Discovery of new gene helps restrict the host range of the modified vaccinia virus Ankara (MVA) which inturn could lead to improved vaccine development against diverse infectious agents.

Discovery of new gene helps restrict the host range of the modified vaccinia virus Ankara (MVA) which inturn could lead to improved vaccine development against diverse infectious agents, stated new study published in the open-access journal PLOS Pathogens by Bernard Moss of the National Institutes of Health, and colleagues.

Safety concerns have led to a preference for attenuated poxviruses that have lost the ability to produce infectious progeny in human cells. The most widely used poxvirus vector is MVA, which exhibits extreme host-range restriction, having lost the inability to efficiently produce infectious virus in most mammalian cells. Despite ongoing clinical testing of MVA-vectored vaccines, the basis for its host-range restriction remains unknown. In the new study, Moss and colleagues set out to identify specific genes that contribute to the host-range defect of MVA. Moss says, "the task of identifying the basis for the attenuation of MVA was complicated because the parental virus had been passaged more than 500 times in chicken embryo fibroblasts, resulting in changes in 124 genes." Through whole-genome sequencing of a panel of MVAs with experimentally extended host ranges, the researchers identified serine protease inhibitor 1 (SPI-1) as one of several candidate host-range factors present in those viruses that have gained the ability to replicate in human cells. Reintroduction of the SPI-1 gene into MVA or host cells increased virus spread by more than 100-fold in a human cell line, providing an important insight into the mechanism responsible for host-range restriction. Furthermore, cells stably expressing SPI-1 also showed enhanced replication of MVA. According to the authors, the results are an important step toward the goal of understanding the basis for human host-range restriction and the attenuation of a vector that forms the basis of numerous vaccines in clinical trials.

Monkeypox - Causes, Symptoms, Signs, Diagnosis, Treatment, Prevention
Monkeypox infection is a zoonotic viral infection that usually lasts for 3 weeks. It is caused by the monkeypox virus and is characterized by rash or pox-like symptoms.

‘Poxvirus vectors have outstanding properties for the development of vaccines against various infectious agents.’

Source-Eurekalert

Test Your Knowledge on Chickenpox
Chickenpox is one of the common infectious diseases in our country which spreads through the tiny droplets of saliva and nasal mucus in the sneezes and coughs of an infected person. However, there are many doubts that we still have about the disease. Let’s see how well you fare in this quiz on chickenpox which covers most of the doubts on the disease. The answers to these will put your doubts to rest.

Chicken Pox Virus Linked to Giant Cell Arteritis in the Elderly
A new study links the virus that causes chicken pox to a condition that inflames blood vessels on the temples and scalp in elderly people, called giant cell arteritis.

Scientists Urge Against Destruction of Remaining Smallpox Virus Stockplies
Three researchers from United States and Brazil have urged the organization not to destroy the remaining stockpiles as important research on the virus is still ongoing.